Abstract
Many peroxisomal enzymes are controlled at the transcriptional level. This gene regulation is well documented in liver from rodent species and is more important upon peroxisome proliferation, although both phenomena are not always associated. Understanding of this regulation comes largely from studies on PPARs (Peroxisome Proliferator-Activated Receptors). Other transcription factors including thyroid hormone receptors, glucocorticoid receptors, LXR, also influence peroxisomal gene expression often in combination with tissue specific cofactors (co-activators or co-repressors). In human tissues and cells, inducibility of peroxisomal enzymes often has not been investigated. De Craemer (1995) reviewed peroxisome proliferation in human liver diseases caused by a large variety of drugs, metabolites, infectious agents or malignancies. Duclos et al (1997) and many others found that isolated human liver cells are almost resistant to classical peroxisome proliferators (fibrates). Overexpression of mouse PPARa in human cells does not affect expression of peroxisomal fatty acid P-oxidation enzymes while, in these circumstances, the mitochondrial counterpart is subject to regulation (Hsu et al., 2001; Lawrence et al., 2001). Indeed, PPARa activates human muscle carnitine palmitoyl transferase I-CPT I (Mascaro et al 1999). On the other hand, PPAR agonists have been shown to repress human cytochrome CYP4F2-LTB4 ω-hydroxylase promoter (Zhang et al. 2000).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aboushadi N., Shackelford J.E., Jessani N., Gentile A., Krisans S.K., 2000, Characterization of peroxisomal 3-hydroxy-3-methylglutaryl coenzyme A reductase in UT2 cells: sterol biosynthesis, phosphorylation, degradation, and statin inhibition. Biochemistry 39: 237–247.
Barger P.M., Browning A.C., Garner A.N., Kelly D.P., 2001, P38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J Biol Chem. 276: 44495–44501.
Beier K., Volkl A., Fahimi H.D., 1997, TNF-alpha downregulates the peroxisome proliferator activated receptor-alpha and the mRNAs encoding peroxisomal proteins in rat liver. FEBS Lett. 412: 385–7.
Berteaux-Lecellier V., Picard M., Thompson-Coffe C, Zickler D., Panvier-Adoutte A., Simonet J.M., 1995, A nonmammalian homolog of the PAF1 gene (Zellweger syndrome) discovered as a gene involved in caryogamy in the fungus Podospora anserina. Cell. 81: 1043–1051.
Caira F., Clemencet M.C., Cherkaoui-Malki M., Dieuaide-Noubhani M., Pacot C, Van Veldhoven P.P., Latruffe N., 1998, Differential regulation by a peroxisome proliferator of the different multifunctional proteins in guinea pig: cDNA cloning of the guinea pig D- specific multifunctional protein 2. Biochem J. 330: 1361–1368.
Chang C.C., South S., Warren D., Jones J., Moser A.B., Moser H.W., Gould S.J., 1999, Metabolic control of peroxisome abundance. J Cell Sci. 112: 1579–1590.
Chao P.M., Chao C.Y., Lin F.J., Huang C, 2001, Oxidized frying oil up-regulates hepatic acyl-CoA oxidase and cytochrome P450 4 Al genes in rats and activates PPARalpha. J Nujr. 131:3166–3174.
Cherkaoui-Malki M., Meyer K., Cao W.Q., Latruffe N., Yeldandi A.V., Rao M.S., Bradfield C.A., Reddy J.K., 2001, Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. Gene Express. 9: 291–304.
Chu R, Madison L.D., Lin Y., Kopp P., Rao M.S., Jameson J.L., Reddy J.K., 1995, Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Proc Natl Acad Sci U S A. 92: 11593–11597.
Cimini A., Cristiano L., Bernardo A., Farioli-Vecchioli S., Stefanini S., Ceru M.P., 2000, Presence and inducibility of peroxisomes in a human glioblastoma cell line. Biochim BiophysActa. 1414 397–409.
Cooper P.J., Danpure C.J., Simpson K.J., 1989, Peroxisomal and mitochondrial proliferation and increased alanine glyoxylate aminotransferase activity in human liver after chlorpromazine-induced cholestasis. Biochem Soc Trans 17: 1071–1072.
De Craemer D., 1995. Secondary alterations of human hepatocellular peroxisomes. J Inherit MetabDis. 18 Suppl 1:181–213.
De Craemer D., Vamecq J., Roels F., Vallee L., Pauwels M., Van den Branden C, 1994, Peroxisomes in liver, heart, and kidney of mice fed a commercial fish oil preparation: original data and review on peroxisomal changes induced by high-fat diets. J Lipid Res. 35: 1241–1250.
Depreter M., Vandesompele J., Espeel M., Speleman F., Roels F., 2002, Modulation of the peroxisomal gene expression pattern by dehydroepiandrosterone and vitamin D: therapeutic implications. J Endocrinol.il 175: 779–792.
Duclos S., Bride J., Ramirez L.C., Bournot P., 1997, Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate. Eur J Cell Biol. 72: 314–323.
El Kebbaj M.S., Malki M.C., Latruffe N., 1996, Properties of peroxisomes from jerboa (Jaculus orientalis). Eur J Cell Biol. 70: 150–156.
Fan C.Y., Pan L., Usuda N., Yeldandi A.V., Rao M.S., Reddy J.K., 1998, Steatohepatitis, spontaneaous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. J Biol Chem 273: 15639–15645
Ferdinandusse S., Denis S., Mooijer P.A., Zhang Z., Reddy J.K., Spector A.A., Wanders R.J., 2001, Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J Lipid Res. 42: 1987–1995.
Girnun G.D., Domann F.E., Moore S.A., Robbins M.E.C., 2002, Identification of a functional Peroxisome Proliferator-Activated Receptor Response Element in the rat catalase promoter. olEndo. 16: 2793–2801.
Hertz R., Sheena V., Kalderon B., Berman I., Bar-Tana J., 2001, Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators. Biochem Pharmacol 61: 1057–1062.
Horie S., Suga T., 1989, Turnover of fatty acyl-CoA oxidase in the liver of rats fed on a partially hydrogenated marine oil. Lipids. 24: 890–894
Hsu M.H., Savas U., Griffin K.J., Johnson E.F., 2001, Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells. J Biol Chem. 276: 27950–27958.
Juge-Aubry CE., Kuenzli S., Sanchez J.C., Hochstrasser D., Meier C.A., 2001, Peroxisomal bifunctional enzyme binds and activates the activation function-1 region of the peroxisome proliferator-activated receptor alpha. Biochem J. 353: 253–258.
Just W.W., Hartl F.U., 1983, Rat liver peroxisomes, II. Stimulation of peroxisomal fatty-acid beta-oxidation by thyroid hormones. Hoppe Seylers Z Physiol Chem. 364: 1541–1547.
Kassam A., Capone J.P., Rachubinski R.A., 2001, The short heterodimer partner receptor differentially modulates peroxisome proliferator-activated receptor alpha-mediated transcription from the peroxisome proliferator-response elements of the genes encoding the peroxisomal beta-oxidation enzymes acyl-CoA oxidase and hydratase-dehydrogenase. Mol Cell Endocrinol. 176: 49–56.
Kassam A., Winrow C.J., Fernandez-Rachubinski F., Capone J.P., Rachubinski R.A., 2000, The peroxisome proliferator response element of the gene encoding the peroxisomal beta-oxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptor beta/9-cis-retinoic acid receptor-mediated transactivation. J Biol Chem. 275: 4345–4350.
Kiema T.R., Taskinen J.P., Pirila P.L., Koivuranta K.T., Wierenga R.K., Hiltunen J.K., 2002, Organization of the multifunctional enzyme type 1: interaction between N- and C-terminal domains is required for the hydratase-1/isomerase activity. Biochem J. 367: 433–441.
Lampen A., Carlberg C, Nau H., 2001, Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives. Eur J Pharmacol. 431: 25–33.
Latruffe N., Malki M.C., Nicolas-Frances V., Clemencet M.C., Jannin B., Berlot J.P., 2000, Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases. Biochem Pharmacol. 60: 1027–1032.
Lawrence J.W., Li Y., Chen S., DeLuca J.G., Berger J.P., Umbenhauer D.R., Moller D.E., Zhou G., 2001, Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson. J Biol Chem. 276: 31521–31527.
Lazennec G., Canaple L., Saugy D., Wahli W., 2000, Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol. 14:1962–1975.
Lemberger, T., Saladin, R., Vázquez, M, Assimacopoulos, F., Staels, B., Desvergne, B., Wahli, W., Auwerx, J., 1996, Expression of the peroxisome proliferator-activated receptor gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 271: 1764–1769.
Mascaro C, Acosta E., Ortiz J.A., Marrero P.F., Hegardt F.G., Haro D., 1998, Related Articles, LinksControl of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem. 273: 8560–8563.
Meertens L.M., Miyata K.S., Cechetto J.D., Rachubinski R.A., Capone J.P., 1998, A mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARalpha. EMBOJ. 17: 6972–6978.
Miyata K.S., McCaw S.E., Meertens L.M., Patel H.V., Rachubinski R.A., Capone J.P., 1998, Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor alpha and liver-X-receptor alpha. Mol Cell Endocrinol. 146: 69–76.
Miyata K.S., McCaw S.E., Patel H.V., Rachubinski R.A., Capone J.P., 1996, The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J Biol Chem. 271: 9189–9192.
Mochizuki K., Suruga K., Sakaguchi N., Takase S., Goda T., 2002, Major intestinal coactivator p300 strongly activates peroxisome proliferator-activated receptor in intestinal cell line, Caco-2. Gene. 291: 271–277.
Motojima K., Passilly P., Peters J.M., Gonzalez F.J., Latruffe N., 1998, Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue-and inducer-specific manner. J Biol Chem. 273:16710–16714.
Moya-Camarena S.Y., Vanden Heuvel J.P., Blanchard S.G., Leesnitzer L.A., Belury M.A., 1999, Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res. 40:1426–1433.
Nilakantan V., Li Y., Glauert H.P., Spear B.T., 1996. Increased liver-specific catalase activity in transgenic mice. DNA Cell Biol. 15: 625–630.
Nicolas-Frances V., Dasari V.K., Abruzzi E., Osumi T., Latruffe N., 2000, The peroxisome proliferator response element (PPRE) present at positions -681/-669 in the rat liver 3- ketoacyl-CoA thiolase B gene functionally interacts differently with PPARalpha and HNF- 4. Biochem. Biophys. Res. Commun. 269: 347–351.
Novikov D.K., Kamps, M.E., 2001. Characterisation of the promoter region of the human peroxisome multifunctional enzyme type2 gene. Biochem. Biophys. Res. Commun. 284: 226–231.
Ostlund Farrants A.K., Bjorkhem I., Pedersen J.I., 1990, Differential induction of peroxisomal oxidation of palmitic acid and 3 alpha,7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid in rat liver. Biochim Biophys Acta. 1046 173–177.
Pacot C, Charmoillaux ML, Goudonnet H., Truchot R.C., Latruffe N., 1993. Role of thyroid state on induction by ciprofibrate of laut-rate hydroxylase and peroxisomal enzymes in rat liver microsomes. Biochem pharmacol. 45: 1437–1446.
Petriv O.I., Pilgrim D.B., Rachubinski R.A., Titorenko V.I., 2002, RNA interference of peroxisome-related genes in C. elegans: a new model for human peroxisomal disorders. Physiol Genomics. 10: 79–91.
Pineda Torra I., Claudel T., Duval C, Kosykh V., Fruchart J.C., Staels, B., 2003, Bile acids induce the expression of the human peroxisome proliferator activated receptor alpha gene via activation of the farnesoid X receptor. Mol Endocrinol.il 17: 259–272.
Reddy J.K., Hashimoto T., 2001, Peroxisomal ß-oxidation and Peroxisome Proliferator- Activated Receptors a: an adaptative metabolic system. Ann Rev Nutr. 21: 193–230.
Pineau T., Hudgins W.R., Liu L., Chen L.C., Sher T., Gonzalez F.J., Samid D., 1996, Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs. Biochem Pharmacol. 52: 659–667.
Reddy J.K., Suga T., Mannaerts G.P., Lazarow P.B., Subramani S., 1996, Peroxisome, biology and role in toxicology and disease. Ann N Y Acad Sci. 804: 1–801.
Rylott E.L., Hooks M.A., Graham,I.A., 2001, Co-ordinate regulation of genes involved in stirage lipid mobilization in Arabidopsis thaliana. Biochem Soc Trans. 29: 283–287
Sakuma M., Yamada J., Suga T., 1993, Induction of peroxisomal beta-oxidation by structural analogues of dehydroepiandrosterone in cultured rat hepatocytes: structure-activity relationships. Biochim Biophys Acta. 1169 66–72.
Shi Y., Hon M., Evans R.M., 2002, The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Proc Natl Acad Sci US A. 99: 2613–2618.
Sinal C.J., Yoon M, Gonzalez F.J., 2001.Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids. J Biol Chem. 276: 47154–47162.
Stolz D.B., Zamora R., Vodovotz Y., Loughran P.A., Billiar T.R., Kim Y.M., Simmons R.L., Watkins S.C., 2002, Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology. 36: 81–93.
Stulnig T.M., Steffensen K. R., Gao, H., Reimers, M., Dahlman-Wright K., Schuster G.U., Gustafsson J.-A., 2002, Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol Pharmacol. 62: 1299–1305.
Surapureddi S., Yu S., Bu H., Hashimoto T., Yeldandi A.V., Kashireddy P., Cherkaoui-Malki M., Qi C, Zhu Y.J., Rao M.S., Reddy J.K., 2002, Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc Natl Acad Sci U S A. 99: 11836–11841.
Thomassen M.S., Christiansen E.N., Norum K.R., 1982, Characterization of the stimulatory effect of high-fat diets on peroxisomal beta-oxidation in rat liver. Biochem J. 206: 195–202.
Tobin K.A., Steineger H.H., Alberti S., Spydevold O., Auwerx J., Gustafsson J.A., Nebb H.I., 2000, Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha. Mol Endocrinol. 14: 741–752.
Vamecq J., 1987, Chlorpromazine and carnitine-dependency of rat liver peroxisomal beta-oxidation of long-chain fatty acids. Biochem J. 241: 783–791
Vamecq J., Latruffe N., 1999, Medical significance of peroxisome proliferator-activated receptors. Lancet. 354(9173): 141–148.
Vamecq J., Roels F., Van den Branden C, Draye J.P., 1987, Peroxisome proliferation in heart and liver of mice receiving chlorpromazine, ethyl 2(5(4-chlorophenoyl)pentyl)oxiran-2- carboxylic acid or hight fat diet; a biochemical and morphometrical comparative study. Pediatries. 22: 748–754.
Van den Branden C, Vamecq J., Wybo I,. Roels F., 1986, Phytol and peroxisome proliferation. PediatrRes. 20: 411–415.
Yamada J., Sugiyama H., Tamura H., Suga T., 1994, Hormonal modulation of peroxisomal enzyme induction caused by peroxisome proliferators: suppression by growth and thyroid hormones in cultured rat hepatocytes. Arch Biochem Biophys. 31: 555–557.
Zhang X., Chen L., Hardwick J.P., 2000, Promoter activity and regulation of the CYP4F2 leukotriene B(4) omega-hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells. Arch Biochem Biophys. 378: 364–376.
Zhou Y.C., Davey H.W., McLachlan M.J., Xie T., Waxman D.J., 2002, Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways. Toxicol Appl Pharmacol 182: 1–10.
Zipper J., 1997, Proliferation of myocardial peroxisomes caused by several agents and conditions. J Mol Cell Cardiol 29: 149–161.
Zomer A.W., van Der Burg B., Jansen G.A., Wanders R.J., Poll-The B.T., van Der Saag P.T., 2000, Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. J Lipid Res. 41: 1801–1807.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this paper
Cite this paper
Latruffe, N. et al. (2003). Gene Regulation of Peroxisomal Enzymes by Nutrients, Hormones and Nuclear Signalling Factors in Animal and Human Species. In: Roels, F., Baes, M., De Bie, S. (eds) Peroxisomal Disorders and Regulation of Genes. Advances in Experimental Medicine and Biology, vol 544. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9072-3_28
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9072-3_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4782-8
Online ISBN: 978-1-4419-9072-3
eBook Packages: Springer Book Archive